Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01612338 · ClinicalTrials.gov registry record · NA
Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives
A NA study of Breast Cancer and Breast Cancer in Young Women, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 1,290
- Enrollment target
- 2
- Study locations
NCT01612338: Completed NA study of Breast Cancer and Breast Cancer in Young Women, sponsored by University of Michigan.
NCT01612338 is a NA study of Breast Cancer and Breast Cancer in Young Women that has completed, run by University of Michigan. The registered enrollment target is 1,290 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01612338, a NA study of Breast Cancer and Breast Cancer in Young Women, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,290 participants
- Enrollment target
- 2
- Study locations
Study Summary
The University of Michigan (UM) Schools of Nursing, Public Health, and Medicine, the Michigan Department of Community Health (MDCH) and the Michigan Cancer Consortium (MCC) are conducting a multidisciplinary academic/practice three-year project to increase appropriate breast cancer screening for young breast cancer survivors and their cancer-free, female relatives at greatest risk for breast cancer. The aims of this project are to: 1) identify and survey 3000 breast cancer survivors reported to the Michigan Cancer Surveillance Program who were diagnosed between the ages of 20-45 years regarding their breast cancer screening utilization; 2) identify and survey the survivors' female relatives regarding their breast cancer screening utilization; and 3) implement two versions (targeted vs. enhanced tailored) of an evidence-based intervention recommended by the Guide to Community Preventive Services to increase breast cancer screening. A follow-up survey will assess the effectiveness of each intervention on a) breast cancer screening utilization; b) perceived barriers and facilitators to screening; c) self-efficacy in utilizing screening services; d) family support related to screening; e) knowledge of the genetics of breast cancer and personal risk factors; and f) satisfaction with the intervention.
Primary Outcome
self report of mammogram and clinical breast exam
Conditions Studied
Interventions
- BEHAVIORAL Targeted
- BEHAVIORAL Enhanced Tailored
Study Locations (2)
Michigan
- University of Michigan School of Nursing - Ann Arbor
- Michigan Department of Community Health - Lansing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,290 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT01612338 record still lists
NCT01612338 is an interventional study that assigns participants to a tested intervention. Its 1,290 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (54% lower).
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Targeted is the first listed.
NCT01612338 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01612338 about?
NCT01612338 is a clinical study titled "Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives". The University of Michigan (UM) Schools of Nursing, Public Health, and Medicine, the Michigan Department of Community Health (MDCH) and the Michigan Cancer Consortium (MCC) are conducting a multidisciplinary academic/practice three-year project to increase appropriate breast cancer screening for you...
What is the current status of trial NCT01612338?
This trial is currently completed. It is a NA study. The enrollment target is 1,290 participants. The study started on 2012-07. Estimated completion is 2014-09.
What conditions does trial NCT01612338 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer in Young Women, Breast Cancer in Women With a Strong Family History.
What interventions are being tested in trial NCT01612338?
The interventions under investigation include: Targeted (BEHAVIORAL), Enhanced Tailored (BEHAVIORAL).
Who is sponsoring clinical trial NCT01612338?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01612338 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01612338's enrollment target sits among peer trials
1,290 95th of 1224 higher than 1,130 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05595642 · 1,290 participants · Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- NCT05812807 · 1,295 participants · Phase 3
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
- NCT06626022 · 1,284 participants · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia